Open Nav

Medicure Inc.

create more investor interest

  • Date:Wednesday, October 17
  • Time:3:30 PM - 3:45 PM
  • Room:Olympic
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Publicly Traded Company
  • Company Description/Mission Statement:Medicure’s vision is to become a leading cardiovascular pharmaceutical company within the U.S, offering a growing product portfolio of cardiovascular products that improve patients’ lives.
  • Company
  • Company HQ City:Winnipeg
  • Company HQ Country:Canada
  • Company HQ State:Manitoba
  • Market Cap:100,000,000
  • Ticker:MPH
  • Exchange:TSX
  • CEO/Top Company Official:Albert D. Friesen, PhD
  • Year Founded:1997
  • Main Therapeutic Focus:Cardiovascular
  • Lead Product in Development :Aggrastat
  • Development Phase of Primary Product:Multiple Products in Market